skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 4
Patent #:
Issue Dt:
05/13/2014
Application #:
10592725
Filing Dt:
10/06/2006
Publication #:
Pub Dt:
05/15/2008
Inventors:
Harm Veenstra, Wouter De Graaff
Title:
X-RAY VISIBLE DRUG DELIVERY DEVICE
Assignment: 1
Reel/Frame:
018308/0924Recorded: 09/27/2006Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
09/06/2006
Exec Dt:
09/06/2006
Assignee:
KLOOSTERSTRAAT 6
OSS, NETHERLANDS 5349 AB
Correspondent:
SUSAN HESS
7 LIVINGSTONE AVENUE
AKZO NOBEL INC. - IP DEPT.
DOBBS FERRY, NY 10522
Assignment: 2
Reel/Frame:
027307/0482Recorded: 12/01/2011Pages: 20
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/31/2011
Assignee:
KLOOSTERSTRAAT 6
5349 AB OSS, NETHERLANDS
Correspondent:
LANNING G. BRYER
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
Assignment: 3
Reel/Frame:
029939/0001Recorded: 03/07/2013Pages: 86
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/01/2013
Assignee:
KLOOSTERSTRAAT 6
AB OSS, NETHERLANDS 5349
Correspondent:
SCOTT J. LEBSON
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
Assignment: 4
Reel/Frame:
029940/0296Recorded: 03/08/2013Pages: 98
Conveyance:
MERGER (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/02/2013
Assignee:
WAARDERWEG 39
BN HAARLEM, NETHERLANDS 2031
Correspondent:
SCOTT J. LEBSON
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018

Search Results as of: 05/26/2024 03:25 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT